Emcure Pharma share surge 6 percent after healthy Q2 earnings show - Moneycontrol

EMCURE Stock   1,373  16.15  1.16%   
About 62% of Emcure Pharmaceuticals' investor base is looking to short. The analysis of the overall prospects from investing in Emcure Pharmaceuticals suggests that many traders are, at the present time, alarmed. The current market sentiment, together with Emcure Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Emcure Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
Emcure Pharma share surge 6 percent after healthy Q2 earnings show Moneycontrol

Read at news.google.com
Google News at Macroaxis
  

Emcure Pharmaceuticals Fundamental Analysis

We analyze Emcure Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Emcure Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Emcure Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Emcure Pharmaceuticals is rated below average in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Emcure Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Emcure Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Emcure Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Emcure Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Emcure Pharmaceuticals Related Equities

KINGFAKingfa Science   3.71   
0%
97.0%
AKUMSAkums Drugs   2.18   
0%
57.0%
GATECHDVRGACM Technologies   1.03   
0%
27.0%
EMCUREEmcure Pharmaceuticals   1.16   
30.0%
0%
PARAGMILKParag Milk   1.83   
48.0%
0%
RICOAUTORico Auto   2.90   
76.0%
0%
TBZTribhovandas Bhimji   3.31   
87.0%
0%
COSMOFIRSTCOSMO FIRST   3.33   
87.0%
0%
DELTAMAGNTDelta Manufacturing   3.44   
90.0%
0%
INNOVACAPInnova Captab   3.79   
100.0%
0%

Complementary Tools for Emcure Stock analysis

When running Emcure Pharmaceuticals' price analysis, check to measure Emcure Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emcure Pharmaceuticals is operating at the current time. Most of Emcure Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Emcure Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emcure Pharmaceuticals' price. Additionally, you may evaluate how the addition of Emcure Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories